Skip to main content
. 2022 Nov 30;14(12):2663. doi: 10.3390/pharmaceutics14122663

Figure 3.

Figure 3

Scheme of processes involved in the oral absorption of rosmarinic acid (RA) and its remaining fraction after gastrointestinal stability (Fgi), intestinal absorption (FCaco-2), hepatic metabolism (FHepG2) and total oral bioavailability (Fabs), evaluated by in vitro methods.